Your browser doesn't support javascript.
loading
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Papatheodoridis, G V; Hatzakis, A; Cholongitas, E; Baptista-Leite, R; Baskozos, I; Chhatwal, J; Colombo, M; Cortez-Pinto, H; Craxi, A; Goldberg, D; Gore, C; Kautz, A; Lazarus, J V; Mendão, L; Peck-Radosavljevic, M; Razavi, H; Schatz, E; Tözün, N; van Damme, P; Wedemeyer, H; Yazdanpanah, Y; Zuure, F; Manns, M P.
Afiliación
  • Papatheodoridis GV; Medical School of National, Kapodistrian University of Athens, Athens, Greece.
  • Hatzakis A; Medical School of National, Kapodistrian University of Athens, Athens, Greece.
  • Cholongitas E; Medical School of National, Kapodistrian University of Athens, Athens, Greece.
  • Baptista-Leite R; Institute of Health Sciences, Católica University of Portugal, Lisbon, Portugal.
  • Baskozos I; Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
  • Chhatwal J; Ministry of Health, Athens, Greece.
  • Colombo M; Massachusetts General Hospital' s, Institute for Technology Assessment and Harvard Medical School, Boston, MA, USA.
  • Cortez-Pinto H; Clinical and Research Center Humanitas, Rozzano, Italy.
  • Craxi A; European Association for the Study of the Liver, Geneva, Switzerland.
  • Goldberg D; Faculdade de Medicina, Universidade de Lisbon, Lisbon, Portugal.
  • Gore C; University of Palermo, Palermo, Italy.
  • Kautz A; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK.
  • Lazarus JV; Hepatitis C Trust, World Hepatitis Alliance, London, UK.
  • Mendão L; Leberhilfe Projekt gUG, Cologne, Germany.
  • Peck-Radosavljevic M; Barcelonai Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Razavi H; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Schatz E; Portuguese Activist Group for HIV/AIDS Treatment, Lisbon, Portugal.
  • Tözün N; European AIDS Treatment Group, Brussels, Belgium.
  • van Damme P; Department of Internal Medicine and Gastroenterology, Klagenfurt, Austria.
  • Wedemeyer H; Center for Disease Analysis, Lafayette, CO, USA.
  • Yazdanpanah Y; Correlation Network, Amsterdam, The Netherlands.
  • Zuure F; Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  • Manns MP; Antwerp University, Antwerp, Belgium.
J Viral Hepat ; 25 Suppl 1: 6-17, 2018 03.
Article en En | MEDLINE | ID: mdl-29508946
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C / Hepacivirus / Erradicación de la Enfermedad Tipo de estudio: Prevalence_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Viral Hepat Asunto de la revista: GASTROENTEROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C / Hepacivirus / Erradicación de la Enfermedad Tipo de estudio: Prevalence_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Viral Hepat Asunto de la revista: GASTROENTEROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Grecia